Clinical trial

A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic Asthma

NCT00109200

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-05-01

PhasePHASE3

Study timeline

Study start (unknown)2003-05-01Date precision: month

Registry last updated2013-06-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

Xolair (omalizumab)DRUG

Sponsors & collaborators

Genentech, Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00109200 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.